Literature DB >> 33322767

Bioresearch of New 1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones.

Dominika Szkatuła1, Edward Krzyżak2, Szczepan Mogilski3, Jacek Sapa3, Barbara Filipek3, Piotr Świątek1.   

Abstract

The subject of the work was the synthesis of new derivatives of1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione with potential analgesic and sedative activity. Eight compounds werereceived. The analgesic activity of the new compounds was confirmed in the "hot plate" test and in the "writhing" test. All tested imides 8-15 were more active in the "writhing" test than aspirin, and two of them, 9 and 11, were similar to morphine. In addition, all of the new imides inhibited the locomotor activity in mice to a statistically significant extent, and two of them also prolonged the duration of thiopental sleep.On the basis of the results obtained for the previously synthesized imides and the results presented in this paper, an attempt was madeto determine the relationship between thechemical structure of imides and their analgesic and sedativeproperties.

Entities:  

Keywords:  3,4-pyridinedicarboximide; analgesic and sedativeactivity

Year:  2020        PMID: 33322767      PMCID: PMC7764601          DOI: 10.3390/molecules25245883

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  18 in total

1.  A validated spectrophotometric and liquid chromatography method for determination and purity evaluation of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine.

Authors:  Izabela Muszalska; Helena Sadowska; Dominika Szkatula
Journal:  Farmaco       Date:  2003-07

2.  Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics.

Authors:  L C HENDERSHOT; J FORSAITH
Journal:  J Pharmacol Exp Ther       Date:  1959-03       Impact factor: 4.030

3.  Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines.

Authors:  N B EDDY; D LEIMBACH
Journal:  J Pharmacol Exp Ther       Date:  1953-03       Impact factor: 4.030

4.  Synthesis and properties of 4-alkoxy-2-[2-hydroxy-3-(4-o,m,p-halogenoaryl-1 -piperazinyl)propyl]-6-methyl-1H-pyrrolo-[3,4-c]pyridine-1,3(2H)-diones with analgesic and sedative activities.

Authors:  Helena Sladowska; Aleksandra Sabiniarz; Dominika Szkatuła; Barbara Filipek; Jacek Sapa
Journal:  Acta Pol Pharm       Date:  2006 Jul-Aug       Impact factor: 0.330

5.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

6.  Investigations on the synthesis and pharmacological properties of 4-alkoxy-2-[2-hydroxy-3-(4-aryl-1-piperazinyl)propyl]-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones.

Authors:  Helena Sladowska; Barbara Filipek; Dominika Szkatuła; Aleksandra Sabiniarz; Małgorzata Kardasz; Joanna Potoczek; Maria Sieklucka-Dziuba; Grazyna Rajtar; Zdzisław Kleinrok; Tadeusz Lis
Journal:  Farmaco       Date:  2002-11

7.  Antinociceptive, antiedematous, and antiallodynic activity of 1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives in experimental models of pain.

Authors:  Anna Dziubina; Dominika Szkatuła; Joanna Gdula-Argasińska; Magdalena Kotańska; Barbara Filipek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-19       Impact factor: 3.000

8.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

9.  Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.

Authors:  Sangsu Bang; Jiho Yoo; Xingrui Gong; Di Liu; Qingjian Han; Xin Luo; Wonseok Chang; Gang Chen; Sang-Taek Im; Yong Ho Kim; Judith A Strong; Ma-Zhong Zhang; Jun-Ming Zhang; Seok-Yong Lee; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2018-01-15       Impact factor: 5.203

10.  Synthesis, Cyclooxygenases Inhibition Activities and Interactions with BSA of N-substituted 1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones Derivatives.

Authors:  Edward Krzyżak; Dominika Szkatuła; Benita Wiatrak; Tomasz Gębarowski; Aleksandra Marciniak
Journal:  Molecules       Date:  2020-06-25       Impact factor: 4.411

View more
  2 in total

1.  The 2-hydroxy-3-(4-aryl-1-piperazinyl)propyl Phthalimide Derivatives as Prodrugs-Spectroscopic and Theoretical Binding Studies with Plasma Proteins.

Authors:  Aleksandra Marciniak; Aleksandra Kotynia; Dominika Szkatuła; Edward Krzyżak
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 2.  An Overview of the Biological Activity of Pyrrolo[3,4-c]pyridine Derivatives.

Authors:  Anna Wójcicka; Aleksandra Redzicka
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.